Mr David Ralph Trinidad, ARNP-C | |
888 Swift Blvd, Richland, WA 99352 | |
(509) 946-4611 | |
(509) 942-2185 |
Full Name | Mr David Ralph Trinidad |
---|---|
Gender | Male |
Speciality | Nurse Practitioner - Acute Care |
Location | 888 Swift Blvd, Richland, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164851069 | NPI | - | NPPES |
1164851069 | Medicaid | WA |
Entity Name | Mercy Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
To address the forecasted public health workforce shortage, The University of Texas Health Science Center at Houston and The University of Texas Health Science Center at San Antonio have created a four-year Doctor of Medicine /Master of Public Health program.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, North Carolina Children's Hospital is one of 27 sites across the nation developing a disease registry for inflammatory bowel diseases (IBD). The research collaborative is part of a $12-million grant to Cincinnati Children's Hospital Medical Center, enabling the creation of this first-of-its-kind registry system providing real time information on thousands of IBD cases across the country and, eventually, around the world.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, will participate in two industry events this month: The 13th Annual DIA Workshop in Japan for Clinical Data Management (Booths 4 and 5) and VIB Pharma's 11th Annual Clinical Trial Supply (Booth 3).
The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-experienced adults who are experiencing virologic failure with HIV-1 strains resistant to an NNRTI and other antiretroviral (ARV) agents.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mr David Ralph Trinidad, ARNP-C 560 Gage Blvd, Suite 203, Richland, WA 99352 Ph: (509) 942-3627 | Mr David Ralph Trinidad, ARNP-C 888 Swift Blvd, Richland, WA 99352 Ph: (509) 946-4611 |
News Archive
To address the forecasted public health workforce shortage, The University of Texas Health Science Center at Houston and The University of Texas Health Science Center at San Antonio have created a four-year Doctor of Medicine /Master of Public Health program.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, North Carolina Children's Hospital is one of 27 sites across the nation developing a disease registry for inflammatory bowel diseases (IBD). The research collaborative is part of a $12-million grant to Cincinnati Children's Hospital Medical Center, enabling the creation of this first-of-its-kind registry system providing real time information on thousands of IBD cases across the country and, eventually, around the world.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, will participate in two industry events this month: The 13th Annual DIA Workshop in Japan for Clinical Data Management (Booths 4 and 5) and VIB Pharma's 11th Annual Clinical Trial Supply (Booth 3).
The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-experienced adults who are experiencing virologic failure with HIV-1 strains resistant to an NNRTI and other antiretroviral (ARV) agents.
› Verified 7 days ago
Tracy Candace W. Degenstein, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 945 Goethals Dr Ste 300, Richland, WA 99352 Phone: 509-392-5220 | |
Kathryn S Brault, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1305 Mansfield St Ste 4, Richland, WA 99352 Phone: 509-946-6124 Fax: 866-692-4493 | |
Ms. Anne Campbell Laucella, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 888 Swift Blvd, Richland, WA 99352 Phone: 509-946-4611 Fax: 509-942-2648 | |
Ms. Jennifer Lee Barden, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1601 George Washington Way, Richland, WA 99354 Phone: 888-227-3312 Fax: 509-622-2707 | |
Christa Heidi Moore, ADN,BSN,MSN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 888 Swift Blvd, Richland, WA 99352 Phone: 509-942-2630 Fax: 509-942-2007 | |
Antonette Lynn Harvill, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 888 Swift Blvd., Richland, WA 99352 Phone: 509-946-4611 Fax: 509-942-2887 | |
Connie L Chen, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 560 Gage Blvd Ste 101&206, Richland, WA 99352 Phone: 509-942-3286 Fax: 509-628-1354 |